Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.80 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.64 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.64 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.64 |
| ▸ | TYMS | P04818 | 1/20 | 0.55 |
| ▸ | POLG | P54098 | 1/20 | 0.54 |
| ▸ | NT5E | P21589 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17833253 | 1.00 | POLB (0.80) | POLBP2RY2P2RY4P2RY6TYMS | |
| SCHEMBL12940502 | 1.00 | POLB (0.80) | POLBP2RY2P2RY4P2RY6TYMS | |
| SCHEMBL18784963 | 1.00 | POLB (0.80) | POLBP2RY2P2RY4P2RY6TYMS | |
| SCHEMBL1971070 | 1.00 | POLB (0.80) | POLBP2RY2P2RY4P2RY6TYMS | |
| SCHEMBL12595477 | 1.00 | POLB (0.80) | POLBP2RY2P2RY4P2RY6TYMS | |
| SCHEMBL23751346 | 1.00 | POLB (0.80) | POLBP2RY2P2RY4P2RY6TYMS | |
| SCHEMBL29099745 | 0.99 | POLB (0.78) | POLBP2RY2P2RY4P2RY6TYMS | |
| Triphosphate SCHEMBL27909398 | 0.95 | POLB (0.79) | POLBP2RY2P2RY4P2RY6TYMS | |
| SCHEMBL28165218 | 0.93 | POLB (0.70) | POLBP2RY2P2RY4P2RY6TYMS | |
| SCHEMBL18745522 | 0.93 | POLB (0.75) | POLBP2RY2P2RY4P2RY6TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6500 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146277-A1 | APPLICATION FOR PEPTIDE NUCLEIC ACID (PNA) BLOCKER | BECTON, DICKINSON AND COMPANY (US) | 2026-05-28 | — | — | US | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260132399-A1 | BEAD-BASED SINGLE CELL SECRETOME ANALYSIS | BECTON DICKINSON AND CO (US) | 2026-05-14 | — | — | US | claimed |
| CN-122012443-A | Deoxycytidine acid hydroxylase and application thereof | 深圳市儿童医院 | 2026-05-12 | — | — | CN | claimed |
| US-20260125683-A1 | TREATMENT OF CANCERS HAVING A DRUG-RESISTANT MESENCHYMAL CELL STATE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2026-05-07 | — | — | US | claimed |
| US-12584168-B2 | Sample preparation method | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-03-24 | — | — | US | claimed |
| US-20260071254-A1 | POLYMERASE MEDIATED END MODIFICATION OF ABSEQ | BECTON DICKINSON CO (US) | 2026-03-12 | — | — | US | claimed |
| EP-4006168-B1 | METHOD OF CHARACTERIZING A TARGET RIBONUCLEIC ACID (RNA) COMPRISING FORMING A COMPLEMENTARY POLYNUCLEOTIDE WHICH MOVES THROUGH A TRANSMEMBRANE PORE | OXFORD NANOPORE TECH PLC (GB) | 2025-12-17 | — | — | EP | claimed |
| US-12473593-B2 | Method of characterizing a target ribonucleic acid (RNA) comprising forming a complementary polynucleotide which moves through a transmembrane pore | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-11-18 | — | — | US | claimed |
| US-20250347766-A1 | COMMUNICATION DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAM | KABUSHIKI KAISHA TOKAI RIKA DENKI SEISAKUSHO (JP) | 2025-11-13 | — | — | US | claimed |
| EP-0183964-B1 | DNA SEQUENCE | TEIJIN LIMITED (JP) | 1990-03-14 | — | — | EP | claimed |
| EP-0195009-B1 | CHEMICALLY MARKED NUCLEIC ACIDS, UTILIZATION THEREOF AND KIT FOR ITS IMPLEMENTATION | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1989-09-06 | — | — | EP | claimed |
| EP-0320807-A2 | Novel polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1989-06-21 | — | — | EP | claimed |
| US-4786719-A | DNA sequence | TEIJIN, LIMITED (JP) | 1988-11-22 | — | — | US | claimed |
| EP-0195009-A1 | CHEMICALLY MARKED NUCLEIC ACIDS, UTILIZATION THEREOF AND KIT FOR ITS IMPLEMENTATION. | INST NAT SANTE RECH MED (FR) | 1986-09-24 | — | — | EP | claimed |
| EP-0184187-A2 | Mouse-human chimaeric immunoglobulin heavy chain, and chimaeric DNA encoding it | TEIJIN LIMITED (JP) | 1986-06-11 | — | — | EP | claimed |
| EP-0183964-A1 | DNA sequence | TEIJIN LIMITED (JP) | 1986-06-11 | — | — | EP | claimed |
| US-4577012-A | ABSORPTION ON ACTIVATED CARBON, ELUTION WITH ALKALI HYDROXIDE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-03-18 | — | — | US | claimed |
| WO-1986000074-A1 | CHEMICALLY MARKED NUCLEIC ACIDS, UTILIZATION THEREOF AND KIT FOR ITS IMPLEMENTATION | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M (FR) | 1986-01-03 | — | — | WO | claimed |
| EP-0146743-A2 | Gene fragments derived from human immunoglobulin gene | TEIJIN LIMITED (JP) | 1985-07-03 | — | — | EP | claimed |